Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Daniel Griffin provides a clinical update on COVID-19, then we review an Ad5 vectored SARS-CoV-2 vaccine, reports on remdesivir and hydroxychloroquine, a drug repurposing study, why some patients infect many others, reducing viral transmission, and much more, including listener email.
Hosts: Vincent Racaniello,Dickson Despommier, Alan Dove, Rich Condit, Kathy Spindler and Brianne Barker
Guests: Daniel Griffin and Chuck Knirsch
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Safety of Ad5 vectored COVID-19 vaccine (Lancet)
- Analysis of hydroxychloroquine use (Lancet)
- Remdesivir study (NEJM)
- Ancient COVID-19 history (MMWR)
- Drug repurposing for COVID-19 (bioRxiv)
- Why do few COVID-19 patients infect others? (Science)
- Overdispersion in COVID-19 transmission (Wellcome Open Res)
- Reducing airborne transmission (Science)
- Letters read on TWiV 621
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees.
Send your virology questions and comments to [email protected]